|
1
|
McCarter MD, Lewis JJ, Antonescu CR and
Brennan MF: Extraskeletal osteosarcoma: Analysis of outcome of a
rare neoplasm. Sarcoma. 4:119–123. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lidang Jensen M, Schumacher B, Myhre
Jensen O, Steen Nielsen O and Keller J: Extraskeletal
osteosarcomas: A clinicopathologic study of 25 cases. Am J Surg
Pathol. 22:588–594. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sordillo PP, Hajdu SI, Magill GB and
Golbey RB: Extraosseous osteogenic sarcoma. A review of 48
patients. Cancer. 51:727–734. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bane BL, Evans HL, Ro JY, Carrasco CH,
Grignon DJ, Benjamin RS and Ayala AG: Extraskeletal osteosarcoma. A
clinicopathologic review of 26 cases. Cancer. 65:2762–2770. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Allan CJ and Soule EH: Osteogenic sarcoma
of the somatic soft tissues. Clinicopathologic study of 26 cases
and review of literature. Cancer. 27:1121–1133. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Goldstein-Jackson SY, Gosheger G, Delling
G, Berdel WE, Exner GU, Jundt G, Machatschek JN, Zoubek A, Jurgens
H and Bielack SS: Cooperative Osteosarcoma Study Group COSS:
Extraskeletal osteosarcoma has a favourable prognosis when treated
like conventional osteosarcoma. J Cancer Res Clin Oncol.
131:520–526. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Torigoe T, Yazawa Y, Takagi T, Terakado A
and Kurosawa H: Extraskeletal osteosarcoma in Japan:
Multiinstitutional study of 20 patients from the Japanese
Musculoskeletal Oncology Group. J Orthop Sci. 12:424–429. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Casali PG: Histology- and
non-histology-driven therapy for treatment of soft tissue sarcomas.
Ann Oncol. 23:x167–x169. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Patel SR and Benjamin RS: Primary
extraskeletal osteosarcoma - experience with chemotherapy. J Natl
Cancer Inst. 87:1331–1333. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ahmad SA, Patel SR, Ballo MT, et al:
Extraosseous osteosarcoma: Response to treatment and long-term
outcome. J Clin Oncol. 20:521–527. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bay JO, Ray-Coquard I, Fayette J, et al:
Groupe Sarcome Francais: Docetaxel and gemcitabine combination in
133 advanced soft-tissue sarcomas: a retrospective analysis. Int J
Cancer. 119:706–711. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Eisenhauer EA, Therasse P, Bogaerts J, et
al: New response evaluation criteria in solid tumours: Revised
RECIST guideline (version 1.1). Eur J Cancer. 45:228–247. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Maki RG, Wathen JK, Patel SR, et al:
Randomized phase II study of gemcitabine and docetaxel compared
with gemcitabine alone in patients with metastatic soft tissue
sarcomas: Results of sarcoma alliance for research through
collaboration study 002 [corrected]. J Clin Oncol. 25:2755–2763.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Leu KM, Ostruszka LJ, Shewach D, et al:
Laboratory and clinical evidence of synergistic cytotoxicity of
sequential treatment with gemcitabine followed by docetaxel in the
treatment of sarcoma. J Clin Oncol. 22:1706–1712. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rapkin L, Qayed M, Brill P, Martin M,
Clark D, George BA, Olson TA, Wasilewski-Masker K, Alazraki A and
Katzenstein HM: Gemcitabine and docetaxel (GEMDOX) for the
treatment of relapsed and refractory pediatric sarcomas. Pediatr
Blood Cancer. 59:854–858. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pautier P, Floquet A, Penel N, et al:
Randomized multicenter and stratified phase II study of gemcitabine
alone versus gemcitabine and docetaxel in patients with metastatic
or relapsed leiomyosarcomas: A Federation Nationale des Centres de
Lutte Contre le Cancer (FNCLCC) French Sarcoma Group Study (TAXOGEM
study). Oncologist. 17:1213–1220. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Navid F, Willert JR, McCarville MB, Furman
W, Watkins A, Roberts W and Daw NC: Combination of gemcitabine and
docetaxel in the treatment of children and young adults with
refractory bone sarcoma. Cancer. 113:419–425. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Frustaci S, Gherlinzoni F, De Paoli A, et
al: Adjuvant chemotherapy for adult soft tissue sarcomas of the
extremities and girdles: Results of the Italian randomized
cooperative trial. J Clin Oncol. 19:1238–1247. 2001.PubMed/NCBI
|
|
19
|
Hensley ML, Maki R, Venkatraman E, Geller
G, Lovegren M, Aghajanian C, Sabbatini P, Tong W, Barakat R and
Spriggs DR: Gemcitabine and docetaxel in patients with unresectable
leiomyosarcoma: Results of a phase II trial. J Clin Oncol.
20:2824–2831. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Qi WX, He AN, Tang LN, Shen Z, Lin F and
Yao Y: Efficacy and safety of gemcitabine-docetaxel combination
therapy for recurrent or refractory high-grade osteosarcoma in
China: A retrospective study of 18 patients. Jpn J Clin Oncol.
42:427–431. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
He A, Qi W, Huang Y, Sun Y, Shen Z, Zhao
H, Yang Y and Yao Y: Comparison of pirarubicin-based versus
gemcitabine-docetaxel chemotherapy for relapsed and refractory
osteosarcoma: A single institution experience. Int J Clin Oncol.
18:498–505. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fox E, Patel S, Wathen JK, Schuetze S,
Chawla S, Harmon D, Reinke D, Chugh R, Benjamin RS and Helman LJ:
Phase II study of sequential gemcitabine followed by docetaxel for
recurrent Ewing sarcoma, osteosarcoma, or unresectable or locally
recurrent chondrosarcoma: Results of Sarcoma Alliance for Research
Through Collaboration Study 003. Oncologist. 17:3212012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wilson H: Extraskeletal ossifying tumors.
Ann Surg. 113:95–112. 1941. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gosiengfiao Y, Reichek J, Woodman J,
Ben-Ami T and Walterhouse D: Gemcitabine with or without docetaxel
and resection for recurrent osteosarcoma: the experience at
Children's Memorial Hospital. J Pediatr Hematol Oncol. 34:e63–e65.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gronchi A, Verderio P, De Paoli A, et al:
Quality of surgery and neoadjuvant combined therapy in the ISG-GEIS
trial on soft tissue sarcomas of limbs and trunk wall. Ann Oncol.
24:817–823. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Souhami RL, Craft AW, Van der Eijken JW,
et al: Randomised trial of two regimens of chemotherapy in operable
osteosarcoma: A study of the European Osteosarcoma Intergroup.
Lancet. 350:911–917. 1997. View Article : Google Scholar : PubMed/NCBI
|
